DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome

J Clin Med. 2022 Nov 3;11(21):6532. doi: 10.3390/jcm11216532.

Abstract

Sticky platelet syndrome (SPS) is a thrombophilia caused by the increased aggregability of platelets in response to the addition of low concentrations of epinephrine (EPI) and/or adenosine diphosphate (ADP). Some of the single nucleotide polymorphisms (SNP), alleles and haplotypes of platelet glycoprotein receptors were proved to have a role in the etiology of thrombotic episodes When comparing SPS and the control group, in VEGFA rs3025039, the p value for both CC vs. TT and CT vs. TT analyses was <0.001. Interestingly, no minor TT genotype was present in the SPS group, suggesting the thrombotic pathogenesis of recurrent spontaneous abortions (RSA) in these patients. Moreover, we found a significant difference in the presence of AT containing a risky A allele and TT genotype of ALPP rs13026692 (p = 0.034) in SPS patients when compared with the controls. Additionally, we detected a decreased frequency of the GG (CC) genotype of FOXP3 rs3761548 in patients with SPS and RSA when compared with the control group (p value for the CC (GG) vs. AA (TT) 0.021). This might indicate an evolutionary protective mechanism of the A (T) allele in the SPS group against thrombotic complications in pregnancy. These results can be used for antithrombotic management in such pregnant patients.

Keywords: DNA analysis; antithrombotic treatment; polymorphisms; sticky platelet syndrome.

Grants and funding

It was supported by the project of the Scientific Grant Agency (Vega) 1/0549/19, Vega 1/0168/16, Vega 1/0479/21 and Agency for the Support of Research and Development (APVV) APVV-16-0020 received by our faculty.